When.com Web Search

  1. Ads

    related to: professional medical grade skincare

Search results

  1. Results From The WOW.Com Content Network
  2. 11 dermatologist-approved melasma treatments of 2023

    www.aol.com/news/11-dermatologist-approved...

    Dr. Carmen Castilla, M.D., is a board-certified dermatologist at the New York Dermatology Group in Manhattan specializing in both medical and cosmetic dermatology.

  3. The 8 Best Vitamin A Serums That Smooth and Even Skin ... - AOL

    www.aol.com/8-best-vitamin-serums-smooth...

    Our expert says: “Though technically a cream, it is the consistency of a thick serum and comes from a science-backed, medical-grade skin care company. AlphaRet contains a stabilized form of ...

  4. Theraderm - Wikipedia

    en.wikipedia.org/wiki/Theraderm

    Theraderm is an American manufacturer of clinical-grade skin care products, including anti-aging creams and moisturizers, as well as an acne system under an alternate brand: Reversion. The company was founded in 1996 by board-certified plastic and reconstructive surgeon James Beckman, M.D., who is also a biochemist and adjunct associate ...

  5. These Skincare Products Are the Next Best Thing To ... - AOL

    www.aol.com/skincare-products-next-best-thing...

    For premium support please call: 800-290-4726 more ways to reach us

  6. Intense pulsed light - Wikipedia

    en.wikipedia.org/wiki/Intense_pulsed_light

    Intense pulsed light (IPL) is a technology used by cosmetic and medical practitioners to perform various skin treatments for aesthetic and therapeutic purposes, including hair removal, photorejuvenation (e.g. the treatment of skin pigmentation, sun damage, and thread veins) as well as to alleviate dermatologic diseases such as acne.

  7. Galderma - Wikipedia

    en.wikipedia.org/wiki/Galderma

    Galderma SA is a Swiss domiciled pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it had been held by a consortium of private institutional investors since 2019, until IPO in 2024.